Welcome to our dedicated page for Huntington Bancshares news (Ticker: HBANZ), a resource for investors and traders seeking the latest updates and insights on Huntington Bancshares stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Huntington Bancshares's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Huntington Bancshares's position in the market.
Huntington Bancshares (NASDAQ:HBAN) declared quarterly cash dividends on two series of preferred stock. The 5.70% Series I dividend is $356.25 per share (equivalent to $0.35625 per depositary share), payable June 1, 2026 to holders of record on May 15, 2026. The 5.50% Series L dividend is $343.75 per share (equivalent to $0.34375 per depositary share), payable May 20, 2026 to holders of record on April 30, 2026.